Innovation Research
Our approach to innovation is clear
1. Programmable intelligent vectors
Disruptive potential to establish new industry-standard vector platforms
Anti-oncogenic safety switches
Non-integrating LV for in vivo applications
Vectors with tissue-specific and cell-specific tropism
2. Ligand-modified vectors
Engineering vectors for improved cell targeting, purification and concentration
Tissue specific tropism
Affinity purification
Vector concentration
3. Novel manufacturing technologies
Improving manufacturing yields and vector-specific performance
Engineered vector backbones for improved safety & efficacy
Novel cell line development (LV and gamma-retro) including stable LV producer cell lines
Novel media additives and transfection enhancers